Healthcare News - An Overview
FTC sues key pharmacy reward administrators in excess of insulin costs The agency brought motion towards Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the listing price of lifetime-saving insulin prescription drugs.Sanders swiftly condemned the shift in a state